Antimicrotubular agents inhibit the degradation of chyle cholesterol ester in vivo.
D000818:Animals; D002784:Cholesterol / Q000031:analogs & derivatives* / Q000097:blood; D002788:Cholesterol Esters / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002913:Chyle / Q000378:metabolism*; D002914:Chylomicrons / Q000378:metabolism; D003078:Colchicine / Q000494:pharmacology*; D003513:Cycloheximide / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D014747:Vinblastine / Q000494:pharmacology*
D002788:Cholesterol Esters; D002914:Chylomicrons; D014747:Vinblastine; D002784:Cholesterol; D003513:Cycloheximide; D003078:Colchicine